List of Tables
Table 1. Global Lower Back Pain Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Acute Drug
Table 3. Key Players of Chronic Drug
Table 4. Global Lower Back Pain Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Lower Back Pain Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Lower Back Pain Drug Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Lower Back Pain Drug Market Share by Region (2019-2024)
Table 8. Global Lower Back Pain Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Lower Back Pain Drug Market Share by Region (2025-2030)
Table 10. Lower Back Pain Drug Market Trends
Table 11. Lower Back Pain Drug Market Drivers
Table 12. Lower Back Pain Drug Market Challenges
Table 13. Lower Back Pain Drug Market Restraints
Table 14. Global Lower Back Pain Drug Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Lower Back Pain Drug Market Share by Players (2019-2024)
Table 16. Global Top Lower Back Pain Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lower Back Pain Drug as of 2023)
Table 17. Ranking of Global Top Lower Back Pain Drug Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Lower Back Pain Drug Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Lower Back Pain Drug Product Solution and Service
Table 21. Date of Enter into Lower Back Pain Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Lower Back Pain Drug Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Lower Back Pain Drug Revenue Market Share by Type (2019-2024)
Table 25. Global Lower Back Pain Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Lower Back Pain Drug Revenue Market Share by Type (2025-2030)
Table 27. Global Lower Back Pain Drug Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Lower Back Pain Drug Revenue Market Share by Application (2019-2024)
Table 29. Global Lower Back Pain Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Lower Back Pain Drug Revenue Market Share by Application (2025-2030)
Table 31. North America Lower Back Pain Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Lower Back Pain Drug Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Lower Back Pain Drug Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Lower Back Pain Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Lower Back Pain Drug Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Lower Back Pain Drug Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Lower Back Pain Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Lower Back Pain Drug Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Lower Back Pain Drug Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Lower Back Pain Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Lower Back Pain Drug Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Lower Back Pain Drug Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Lower Back Pain Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Lower Back Pain Drug Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Lower Back Pain Drug Market Size by Country (2025-2030) & (US$ Million)
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer Lower Back Pain Drug Product
Table 49. Pfizer Revenue in Lower Back Pain Drug Business (2019-2024) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Johnson and Johnson Company Detail
Table 52. Johnson and Johnson Business Overview
Table 53. Johnson and Johnson Lower Back Pain Drug Product
Table 54. Johnson and Johnson Revenue in Lower Back Pain Drug Business (2019-2024) & (US$ Million)
Table 55. Johnson and Johnson Recent Development
Table 56. Sanofi Company Detail
Table 57. Sanofi Business Overview
Table 58. Sanofi Lower Back Pain Drug Product
Table 59. Sanofi Revenue in Lower Back Pain Drug Business (2019-2024) & (US$ Million)
Table 60. Sanofi Recent Development
Table 61. Endo Pharmaceuticals Company Detail
Table 62. Endo Pharmaceuticals Business Overview
Table 63. Endo Pharmaceuticals Lower Back Pain Drug Product
Table 64. Endo Pharmaceuticals Revenue in Lower Back Pain Drug Business (2019-2024) & (US$ Million)
Table 65. Endo Pharmaceuticals Recent Development
Table 66. Merck Company Detail
Table 67. Merck Business Overview
Table 68. Merck Lower Back Pain Drug Product
Table 69. Merck Revenue in Lower Back Pain Drug Business (2019-2024) & (US$ Million)
Table 70. Merck Recent Development
Table 71. Dr. Reddy’s Laboratories Company Detail
Table 72. Dr. Reddy’s Laboratories Business Overview
Table 73. Dr. Reddy’s Laboratories Lower Back Pain Drug Product
Table 74. Dr. Reddy’s Laboratories Revenue in Lower Back Pain Drug Business (2019-2024) & (US$ Million)
Table 75. Dr. Reddy’s Laboratories Recent Development
Table 76. Vertebral Technologies Company Detail
Table 77. Vertebral Technologies Business Overview
Table 78. Vertebral Technologies Lower Back Pain Drug Product
Table 79. Vertebral Technologies Revenue in Lower Back Pain Drug Business (2019-2024) & (US$ Million)
Table 80. Vertebral Technologies Recent Development
Table 81. Medtronic Company Detail
Table 82. Medtronic Business Overview
Table 83. Medtronic Lower Back Pain Drug Product
Table 84. Medtronic Revenue in Lower Back Pain Drug Business (2019-2024) & (US$ Million)
Table 85. Medtronic Recent Development
Table 86. Boston Scientific Company Detail
Table 87. Boston Scientific Business Overview
Table 88. Boston Scientific Lower Back Pain Drug Product
Table 89. Boston Scientific Revenue in Lower Back Pain Drug Business (2019-2024) & (US$ Million)
Table 90. Boston Scientific Recent Development
Table 91. BioWave Company Detail
Table 92. BioWave Business Overview
Table 93. BioWave Lower Back Pain Drug Product
Table 94. BioWave Revenue in Lower Back Pain Drug Business (2019-2024) & (US$ Million)
Table 95. BioWave Recent Development
Table 96. Koninklijke Philips Company Detail
Table 97. Koninklijke Philips Business Overview
Table 98. Koninklijke Philips Lower Back Pain Drug Product
Table 99. Koninklijke Philips Revenue in Lower Back Pain Drug Business (2019-2024) & (US$ Million)
Table 100. Koninklijke Philips Recent Development
Table 101. Stayble Therapeutics Company Detail
Table 102. Stayble Therapeutics Business Overview
Table 103. Stayble Therapeutics Lower Back Pain Drug Product
Table 104. Stayble Therapeutics Revenue in Lower Back Pain Drug Business (2019-2024) & (US$ Million)
Table 105. Stayble Therapeutics Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lower Back Pain Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Lower Back Pain Drug Market Share by Type: 2023 VS 2030
Figure 3. Acute Drug Features
Figure 4. Chronic Drug Features
Figure 5. Global Lower Back Pain Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Lower Back Pain Drug Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Other Case Studies
Figure 10. Lower Back Pain Drug Report Years Considered
Figure 11. Global Lower Back Pain Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Lower Back Pain Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Lower Back Pain Drug Market Share by Region: 2023 VS 2030
Figure 14. Global Lower Back Pain Drug Market Share by Players in 2023
Figure 15. Global Top Lower Back Pain Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lower Back Pain Drug as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Lower Back Pain Drug Revenue in 2023
Figure 17. North America Lower Back Pain Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Lower Back Pain Drug Market Share by Country (2019-2030)
Figure 19. United States Lower Back Pain Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Lower Back Pain Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Lower Back Pain Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Lower Back Pain Drug Market Share by Country (2019-2030)
Figure 23. Germany Lower Back Pain Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Lower Back Pain Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Lower Back Pain Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Lower Back Pain Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Lower Back Pain Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Lower Back Pain Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Lower Back Pain Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Lower Back Pain Drug Market Share by Region (2019-2030)
Figure 31. China Lower Back Pain Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Lower Back Pain Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Lower Back Pain Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Lower Back Pain Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Lower Back Pain Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Lower Back Pain Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Lower Back Pain Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Lower Back Pain Drug Market Share by Country (2019-2030)
Figure 39. Mexico Lower Back Pain Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Lower Back Pain Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Lower Back Pain Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Lower Back Pain Drug Market Share by Country (2019-2030)
Figure 43. Turkey Lower Back Pain Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Lower Back Pain Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Pfizer Revenue Growth Rate in Lower Back Pain Drug Business (2019-2024)
Figure 46. Johnson and Johnson Revenue Growth Rate in Lower Back Pain Drug Business (2019-2024)
Figure 47. Sanofi Revenue Growth Rate in Lower Back Pain Drug Business (2019-2024)
Figure 48. Endo Pharmaceuticals Revenue Growth Rate in Lower Back Pain Drug Business (2019-2024)
Figure 49. Merck Revenue Growth Rate in Lower Back Pain Drug Business (2019-2024)
Figure 50. Dr. Reddy’s Laboratories Revenue Growth Rate in Lower Back Pain Drug Business (2019-2024)
Figure 51. Vertebral Technologies Revenue Growth Rate in Lower Back Pain Drug Business (2019-2024)
Figure 52. Medtronic Revenue Growth Rate in Lower Back Pain Drug Business (2019-2024)
Figure 53. Boston Scientific Revenue Growth Rate in Lower Back Pain Drug Business (2019-2024)
Figure 54. BioWave Revenue Growth Rate in Lower Back Pain Drug Business (2019-2024)
Figure 55. Koninklijke Philips Revenue Growth Rate in Lower Back Pain Drug Business (2019-2024)
Figure 56. Stayble Therapeutics Revenue Growth Rate in Lower Back Pain Drug Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed